Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,093 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Novel method utilizing bisulfite conversion with dual amplification-refractory mutation system polymerase chain reaction to detect circulating pancreatic β-cell cfDNA.
Okada A, Yamada-Yamashita M, Tominaga Y, Jo K, Mori H, Suzuki R, Ishizu M, Tamaki M, Akehi Y, Takashi Y, Koga D, Shimokita E, Tanihara F, Kurahashi K, Yoshida S, Mitsui Y, Masuda S, Endo I, Aihara KI, Kagami S, Abe M, Ferreri K, Fujitani Y, Matsuhisa M, Kuroda A. Okada A, et al. Among authors: endo i. J Diabetes Investig. 2022 Jul;13(7):1140-1148. doi: 10.1111/jdi.13806. Epub 2022 May 6. J Diabetes Investig. 2022. PMID: 35396829 Free PMC article.
Carbohydrate-to-insulin ratio is estimated from 300-400 divided by total daily insulin dose in type 1 diabetes patients who use the insulin pump.
Kuroda A, Yasuda T, Takahara M, Sakamoto F, Kasami R, Miyashita K, Yoshida S, Kondo E, Aihara K, Endo I, Matsuoka TA, Kaneto H, Matsumoto T, Shimomura I, Matsuhisa M. Kuroda A, et al. Among authors: endo i. Diabetes Technol Ther. 2012 Nov;14(11):1077-80. doi: 10.1089/dia.2012.0109. Diabetes Technol Ther. 2012. PMID: 23101953
Serum carboxy-terminal telopeptide of type I collagen levels are associated with carotid atherosclerosis in patients with cardiovascular risk factors.
Kondo T, Endo I, Aihara K, Onishi Y, Dong B, Ohguro Y, Kurahashi K, Yoshida S, Fujinaka Y, Kuroda A, Matsuhisa M, Fukumoto S, Matsumoto T, Abe M. Kondo T, et al. Among authors: endo i. Endocr J. 2016 Apr 25;63(4):397-404. doi: 10.1507/endocrj.EJ15-0589. Epub 2016 Feb 13. Endocr J. 2016. PMID: 26877258 Free article.
A vicious cycle between acid sensing and survival signaling in myeloma cells: acid-induced epigenetic alteration.
Amachi R, Hiasa M, Teramachi J, Harada T, Oda A, Nakamura S, Hanson D, Watanabe K, Fujii S, Miki H, Kagawa K, Iwasa M, Endo I, Kondo T, Yoshida S, Aihara KI, Kurahashi K, Kuroda Y, Horikawa H, Tanaka E, Matsumoto T, Abe M. Amachi R, et al. Among authors: endo i. Oncotarget. 2016 Oct 25;7(43):70447-70461. doi: 10.18632/oncotarget.11927. Oncotarget. 2016. PMID: 27626482 Free PMC article.
Synergistic targeting of Sp1, a critical transcription factor for myeloma cell growth and survival, by panobinostat and proteasome inhibitors.
Bat-Erdene A, Miki H, Oda A, Nakamura S, Teramachi J, Amachi R, Tenshin H, Hiasa M, Iwasa M, Harada T, Fujii S, Sogabe K, Kagawa K, Yoshida S, Endo I, Aihara K, Abe M. Bat-Erdene A, et al. Among authors: endo i. Oncotarget. 2016 Nov 29;7(48):79064-79075. doi: 10.18632/oncotarget.12594. Oncotarget. 2016. PMID: 27738323 Free PMC article.
Pim-2 is a critical target for treatment of osteoclastogenesis enhanced in myeloma.
Teramachi J, Hiasa M, Oda A, Harada T, Nakamura S, Amachi R, Tenshin H, Iwasa M, Fujii S, Kagawa K, Miki H, Kurahashi K, Yoshida S, Endo I, Haneji T, Matsumoto T, Abe M. Teramachi J, et al. Among authors: endo i. Br J Haematol. 2018 Feb;180(4):581-585. doi: 10.1111/bjh.14388. Epub 2016 Oct 17. Br J Haematol. 2018. PMID: 27748523 Free article. No abstract available.
1,093 results